Year: 2018
Type: article
Abstract: A reverse pH gradient is a hallmark of cancer metabolism, manifested by extracellular acidosis and intracellular alkalization. While consequences of extracellular acidosis are known, the roles of intracellular alkalization are incompletely understood. By reconstructing and integrating enzymatic pH-dependent activity profiles into cell-specific genome-scale metabolic models, we develop a computational methodology that explores how intracellular pH (pHi) can modulate metabolism. We show that in silico, alkaline pHi maximizes cancer cell proliferation coupled to increased glycolysis and adaptation to hypoxia (i.e., the Warburg effect), whereas acidic pHi disables these adaptations and compromises tumor cell growth. We then systematically identify metabolic targets (GAPDH and GPI) with predicted amplified anti-cancer effects at acidic pHi, forming a novel therapeutic strategy. Experimental testing of this strategy in breast cancer cells reveals that it is particularly effective against aggressive phenotypes. Hence, this study suggests essential roles of pHi in cancer metabolism and provides a conceptual and computational framework for exploring pHi roles in other biomedical domains.
Source: Nature Communications
Institutions: Tel Aviv University, University of Maryland, College Park, Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, University of South Florida, Moffitt Cancer Center, Scripps Research Institute, Institució Catalana de Recerca i Estudis Avançats, National Institutes of Health, National Cancer Institute
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,990
Funders: University of South Florida, Moffitt Cancer Center, Institute for the Promotion of Teaching Science and Technology, European Commission, Israel Science Foundation, National Institutes of Health, National Institute of Standards and Technology, Israeli Centers for Research Excellence, National Cancer Institute, FP7 Ideas: European Research Council
Awards: Cancer as a Complex Adaptive System, G213385853, G310920150, G362094, G4551976579, A systems pharmacology approach to the discovery of novel therapeutics in Alzheimer´s disease, G628083866, Early warning signals of ageing in human stem cells and age-related disorders, G8135003176, G8702093568, Moffitt Cancer Center Support Grant
OpenAlex ID: W2883266145
